Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
McKesson
Cantor Fitzgerald
Chubb
Harvard Business School
Deloitte
Cipla
Accenture
McKinsey

Generated: January 22, 2018

DrugPatentWatch Database Preview

METOLAZONE Drug Profile

« Back to Dashboard

Which patents cover Metolazone, and when can generic versions of Metolazone launch?

Metolazone is a drug marketed by Mylan, Roxane, Sandoz, Teva, and Watson Labs. and is included in eight NDAs.

The generic ingredient in METOLAZONE is metolazone. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the metolazone profile page.
Drug patent expirations by year for METOLAZONE
Pharmacology for METOLAZONE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for METOLAZONE

US Patents and Regulatory Information for METOLAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan METOLAZONE metolazone TABLET;ORAL 076698-001 Dec 23, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METOLAZONE metolazone TABLET;ORAL 076466-002 Dec 19, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane METOLAZONE metolazone TABLET;ORAL 076482-002 Apr 29, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva METOLAZONE metolazone TABLET;ORAL 076600-001 Jan 6, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan METOLAZONE metolazone TABLET;ORAL 076698-002 Oct 19, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan METOLAZONE metolazone TABLET;ORAL 076698-003 Oct 19, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METOLAZONE metolazone TABLET;ORAL 076466-001 Dec 19, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METOLAZONE metolazone TABLET;ORAL 076732-001 Dec 19, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva METOLAZONE metolazone TABLET;ORAL 075543-003 Dec 24, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs METOLAZONE metolazone TABLET;ORAL 076891-001 Jul 21, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Covington
Boehringer Ingelheim
Baxter
Cerilliant
McKesson
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot